PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism

PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone.

Guardado en:
Detalles Bibliográficos
Autores principales: Siddhant U. Jain, Truman J. Do, Peder J. Lund, Andrew Q. Rashoff, Katharine L. Diehl, Marcin Cieslik, Andrea Bajic, Nikoleta Juretic, Shriya Deshmukh, Sriram Venneti, Tom W. Muir, Benjamin A. Garcia, Nada Jabado, Peter W. Lewis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/7a64b34bead04eeeabaa7ea08c232938
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a64b34bead04eeeabaa7ea08c232938
record_format dspace
spelling oai:doaj.org-article:7a64b34bead04eeeabaa7ea08c2329382021-12-02T17:01:26ZPFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism10.1038/s41467-019-09981-62041-1723https://doaj.org/article/7a64b34bead04eeeabaa7ea08c2329382019-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09981-6https://doaj.org/toc/2041-1723PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone.Siddhant U. JainTruman J. DoPeder J. LundAndrew Q. RashoffKatharine L. DiehlMarcin CieslikAndrea BajicNikoleta JureticShriya DeshmukhSriram VennetiTom W. MuirBenjamin A. GarciaNada JabadoPeter W. LewisNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Siddhant U. Jain
Truman J. Do
Peder J. Lund
Andrew Q. Rashoff
Katharine L. Diehl
Marcin Cieslik
Andrea Bajic
Nikoleta Juretic
Shriya Deshmukh
Sriram Venneti
Tom W. Muir
Benjamin A. Garcia
Nada Jabado
Peter W. Lewis
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
description PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone.
format article
author Siddhant U. Jain
Truman J. Do
Peder J. Lund
Andrew Q. Rashoff
Katharine L. Diehl
Marcin Cieslik
Andrea Bajic
Nikoleta Juretic
Shriya Deshmukh
Sriram Venneti
Tom W. Muir
Benjamin A. Garcia
Nada Jabado
Peter W. Lewis
author_facet Siddhant U. Jain
Truman J. Do
Peder J. Lund
Andrew Q. Rashoff
Katharine L. Diehl
Marcin Cieslik
Andrea Bajic
Nikoleta Juretic
Shriya Deshmukh
Sriram Venneti
Tom W. Muir
Benjamin A. Garcia
Nada Jabado
Peter W. Lewis
author_sort Siddhant U. Jain
title PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
title_short PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
title_full PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
title_fullStr PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
title_full_unstemmed PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
title_sort pfa ependymoma-associated protein ezhip inhibits prc2 activity through a h3 k27m-like mechanism
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/7a64b34bead04eeeabaa7ea08c232938
work_keys_str_mv AT siddhantujain pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT trumanjdo pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT pederjlund pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT andrewqrashoff pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT katharineldiehl pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT marcincieslik pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT andreabajic pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT nikoletajuretic pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT shriyadeshmukh pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT sriramvenneti pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT tomwmuir pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT benjaminagarcia pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT nadajabado pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
AT peterwlewis pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism
_version_ 1718382153257975808